Related Experiment Video
Updated: Jun 6, 2025
11:44
Analysis of Combinatorial miRNA Treatments to Regulate Cell Cycle and Angiogenesis
Published on: March 30, 2019
7.5K
miR-29a Downregulates PIK3CA Expression and Inhibits Cervical Cancer Cell Dynamics: A Comparative Clinical Analysis
Hyorim Jeong1, Kangchan Choi2,3, Dasom Hwang3
1College of Engineering and Medicine, University of Illinois Chicago, Chicago, IL 60612, USA.
Current Issues in Molecular Biology
|November 26, 2024
Summary
MicroRNA-29a (miR-29a) effectively suppresses PIK3CA oncogene expression in cervical cancer cells. This inhibition reduces cell division and migration, offering a promising therapeutic strategy for advanced cervical cancer.
Area of Science:
- Oncology
- Molecular Biology
- Biochemistry
Background:
- Cervical cancer screening relies on HPV/Pap tests, but advanced stages present poor outcomes.
- PIK3CA oncogene expression is a known driver of cervical cancer progression.
- Targeting oncogenes offers a potential therapeutic avenue for advanced cervical cancer.
Purpose of the Study:
- To investigate the therapeutic potential of microRNA-29a (miR-29a) in suppressing PIK3CA expression in cervical cancer.
- To evaluate the impact of miR-29a on cervical cancer cell proliferation and migration.
- To correlate miR-29a levels with disease progression in clinical samples.
Main Methods:
- Transfection of cervical cancer cell lines (SiHa, C33A, HeLa) with miR-29a.
- RT-qPCR and Western blot to quantify PIK3CA RNA and protein levels.
- Wound healing and cell migration assays to assess cellular behavior.
- Analysis of miR-29a concentration in patient biopsy samples.
Main Results:
- miR-29a transfection significantly reduced PIK3CA expression at both RNA and protein levels.
- miR-29a inhibited cell division and migration in HeLa cells.
- miR-29a directly binds to the 3'-UTR of PIK3CA, downregulating its expression.
- Lower miR-29a concentrations correlated with advanced cervical cancer progression.
Conclusions:
- miR-29a acts as a tumor suppressor by targeting PIK3CA in cervical cancer.
- miR-29a demonstrates potential as a therapeutic agent to slow cervical cancer progression, particularly in advanced stages.
- Targeting PIK3CA with miR-29a offers a novel strategy for cervical cancer treatment.
Related Concept Videos
01:23Negative Regulator Molecules
35.2K
Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
35.2K
02:23Abnormal Proliferation
4.5K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.5K
02:34Inhibition of Cdk Activity
4.7K
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
4.7K
01:22MicroRNAs
21.2K
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After...
21.2K
03:03mTOR Signaling and Cancer Progression
3.7K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.7K
01:19Interactions Between Signaling Pathways
6.2K
Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
6.2K